Vitamin D and autism spectrum disorder: A literature review

Nutrients

Volumn 8, Issue 4, 2016, Pages

  Mazahery, Hajar ^a   Camargo, Carlos A ^b   Conlon, Cathryn ^a   Beck, Kathryn L ^a   Kruger, Marlena C ^a   von Hurst, Pamela R ^a  

^a MASSEY UNIVERSITY   (New Zealand)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

25(OH)D; ASD; Autism spectrum disorder; Birth; Conception; Ethnicity; Intervention; Latitude; Migration; Review; Season; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; COLECALCIFEROL; ERGOCALCIFEROL; GAMMA INTERFERON; INTERLEUKIN 6; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN D RECEPTOR;

AUTISM; AUTISM DIAGNOSTIC INTERVIEW REVISED; AUTISM DIAGNOSTIC OBSERVATION SCHEDULE; CHILD BEHAVIOR CHECKLIST; CONCEPTION; DSM-III; DSM-IV; ETHNICITY; HUMAN; LIVE BIRTH; MATERNAL NUTRITION; OUTCOME ASSESSMENT; POPULATION MIGRATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; SEASON; SECONDARY PREVENTION; ULTRAVIOLET RADIATION; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM; WECHSLER INTELLIGENCE SCALE FOR CHILDREN; AUTISM SPECTRUM DISORDER; FEMALE; PREGNANCY;

AUTISM SPECTRUM DISORDER; FEMALE; HUMANS; PREGNANCY; VITAMIN D DEFICIENCY;

EID: 84964292324     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu8040236     Document Type: Review

References (199)

1. New Zealand Guidelines Group. What does ASD look like? In A resource to Help Identify Autism Spectrum Disorder; New Zealand Guidelines Group: Wellington, New Zealand, 2010.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: DSM-5; American Psychiatric Publishing: Washington, DC, USA, 2013.
3. Rose, S.; Melnyk, S.; Pavliv, O.; Bai, S.; Nick, T.G.; Frye, R.E.; James, S.J. Evidence of oxidative damage and inflammation associated with low glutathione redox status in the autism brain. Transl. Psychiatry 2012, 2, e134. [CrossRef] [PubMed]
4. Ashwood, P.; Krakowiak, P.; Hertz-Picciotto, I.; Hansen, R.; Pessah, I.; Van de Water, J. Elevated plasma cytokines in Autism Spectrum Disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain Behav. Immun. 2011, 25, 40-45. [CrossRef] [PubMed]
5. Chez, M.G.; Dowling, T.; Patel, P.B.; Khanna, P.; Kominsky, M. Elevation of tumor necrosis factor-alpha in cerebrospinal fluid of autistic children. Pediatr. Neurol. 2007, 36, 361-365. [CrossRef] [PubMed]
6. Napolioni, V.; Ober-Reynolds, B.; Szelinger, S.; Corneveaux, J.J.; Pawlowski, T.; Ober-Reynolds, S.; Kirwan, J.; Persico, A.M.; Melmed, R.D.; Craig, D.W et al. Plasma cytokine profiling in sibling pairs discordant for Autism Spectrum Disorder. J. Neuroinflamm. 2013, 10, 38. [CrossRef] [PubMed]
7. Molloy, C.A.; Morrow, A.L.; Meinzen-Derr, J.; Schleifer, K.; Dienger, K.; Manning-Courtney, P.; Altaye, M.; Wills-Karp, M. Elevated cytokine levels in children with Autism Spectrum Disorder. J. Neuroimmunol. 2006, 172, 198-205. [CrossRef] [PubMed]
8. Rossignol, D.A.; Frye, R.E. Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism. Front. Physiol. 2014, 5, 150. [CrossRef] [PubMed]
9. Singh, V.K. Phenotypic expression of autoimmune autistic disorder (AAD): A major subset of autism. Ann. Clin. Psychiatry 2009, 21, 148-161. [PubMed]
10. Ming, X.; Stein, T.P.; Brimacombe, M.; Johnson, W.G.; Lambert, G.H.; Wagner, G.C. Increased excretion of a lipid peroxidation biomarker in autism. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73, 379-384. [CrossRef] [PubMed]
11. Giulivi, C.; Zhang, Y.; Omanska-Klusek, A.; Ross-Inta, C, Wong, S.; Hertz-Picciotto, I.; Tassone, F.; Pessah, I.N. Mitochondrial dysfunction in autism. JAMA 2010, 304, 2389-2396. [CrossRef] [PubMed]
12. Napoli, E.; Wong, S.; Hertz-Picciotto, I.; Giulivi, C. Deficits in bioenergetics and impaired immune response in granulocytes from children with autism. Pediatrics 2014, 133, e1405-e1410. [CrossRef] [PubMed]
13. Rose, S.; Frye, R.E.; Slattery, J.; Wynne, R.; Tippett, M.; Pavliv, O.; Melnyk, S.; James, S.J. Oxidative stress induces mitochondrial dysfunction in a subset of autism lymphoblastoid cell lines in a well-matched case control cohort. PLoS ONE 2014, 9, e85436. [CrossRef] [PubMed]
14. Melnyk, S.; Fuchs, G.J.; Schulz, E.; Lopez, M.; Kahler, S.G.; Fussell, J.J.; Bellando, J.; Pavliv, O.; Rose, S.; Seidel, L et al. Metabolic imbalance associated with methylation dysregulation and oxidative damage in children with autism. J. Autism Dev. Disord. 2012, 42, 367-377. [CrossRef] [PubMed]
15. Ghezzo, A.; Visconti, P.; Abruzzo, P.M.; Bolotta, A.; Ferreri, C.; Gobbi, G.; Malisardi, G.; Manfredini, S.; Marini, M.; Nanetti, L et al. Oxidative stress and erythrocyte membrane alterations in children with autism: Correlation with clinical features. PLoS ONE 2013, 8, e66418. [CrossRef] [PubMed]
16. Mostafa, G.A.; El-Hadidi, E.S.; Hewedi, D.H.; Abdou, M.M. Oxidative stress in egyptian children with autism: Relation to autoimmunity. J. Neuroimmunol. 2010, 219, 114-118. [CrossRef] [PubMed]
17. Chakrabarti, S.; Fombonne, E. Pervasive Developmental Disorders in preschool children. JAMA 2001, 285, 3093-3099. [CrossRef] [PubMed]
18. Baio, J. Prevalence of Autism Spectrum Disorders—Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008; Morbidity and mortality weekly report; Surveillance summaries; Centers for Disease Control and Prevention: Atlanta, GA, USA, 2012; Volume 61, 1-19.
19. Ghanizadeh, A. A preliminary study on screening prevalence of pervasive developmental disorder in schoolchildren in iran. J. Autism Dev. Disord. 2008, 38, 759-763. [CrossRef] [PubMed]
20. Kogan, M.D.; Blumberg, S.J.; Schieve, L.A.; Boyle, C.A.; Perrin, J.M.; Ghandour, R.M.; Singh, G.K.; Strickland, B.B.; Trevathan, E.; van Dyck, P.C. Prevalence of parent-reported diagnosis of Autism Spectrum Disorder among children in the us, 2007. Pediatrics 2009, 124, 1395-1403. [CrossRef] [PubMed]
21. Hansen, S.N.; Schendel, D.E.; Parner, E.T. Explaining the increase in the prevalence of Autism Spectrum Disorders: The proportion attributable to changes in reporting practices. JAMA Pediatr. 2015, 169, 56-62. [CrossRef] [PubMed]
22. Schaaf, C.P.; Zoghbi, H.Y. Solving the autism puzzle a few pieces at a time. Neuron 2011, 70, 806-808. [CrossRef] [PubMed]
23. Cannell, J.J. Autism and vitamin D. Med. Hypotheses 2008, 70, 750-759. [CrossRef] [PubMed]
24. DeLuca, H.F. Overview of general physiologic features and functions of vitamin D. Am. J. Clin. Nutr. 2004, 80, 1689S-1696S. [PubMed]
25. Holick, M.F.; MacLaughlin, J.A.; Clark, M.B.; Holick, S.A.; Potts, J.T.; Anderson, R.R.; Blank, I.H.; Parrish, J.A.; Elias, P. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 1980, 210, 203-205. [CrossRef] [PubMed]
26. Holick, M.F. Vitamin D deficiency. N. Engl. J. Med. 2007, 357, 266-281. [CrossRef] [PubMed]
27. Clements, M.R.; Davies, M.; Hayes, M.E.; Hlckey, C.D.; Lumb, G.A.; Mawer, E.B.; Adams, P.H. The role of 1,25-dihydroxyvitamin D in the mechanism of acquired vitamin d deficiency. Clin. Endocrinol. (Oxf.) 1992, 37, 17-27. [CrossRef] [PubMed]
28. Zerwekh, J.E. Blood biomarkers of vitamin D status. Am. J. Clin. Nutr. 2008, 87, 1087S-1091S. [PubMed]
29. Ministry of Health and Cancer Society of New Zealand. Consensus Statement on Vitamin D and Sun Exposure in New Zealand; Health, M.O., Ed.; Ministry of Health: Wellington, New Zealand, 2012.
30. Holick, M.F. Vitamin D: A D-lightful health perspective. Nutr. Rev. 2008, 66, S182-S194. [CrossRef] [PubMed]
31. Koˇcovská, E.; Fernell, E.; Billstedt, E.; Minnis, H.; Gillberg, C. Vitamin D and autism: Clinical review. Res. Dev. Disabil. 2012, 33, 1541-1550. [CrossRef] [PubMed]
32. Gentile, I.; Zappulo, E.; Militerni, R.; Pascotto, A.; Borgia, G.; Bravaccio, C. Etiopathogenesis of Autism Spectrum Disorders: Fitting the pieces of the puzzle together. Med. Hypotheses 2013, 81, 26-35. [CrossRef] [PubMed]
33. Elsabbagh, M.; Divan, G.; Koh, Y.J.; Kim, Y.S.; Kauchali, S.; Marcin, C.; Montiel-Nava, C.; Patel, V.; Paula, C.S.; Wang, C et al. Global prevalence of autism and other Pervasive Developmental Disorders. Autism Res. 2012, 5, 160-179. [CrossRef] [PubMed]
34. Wan, Y.; Hu, Q.; Li, T.; Jiang, L.; Du, Y.; Feng, L.; Wong, J.C.-M.; Li, C. Prevalence of Autism Spectrum Disorders among children in China: A systematic review. Shanghai Arch. Psychiatry 2013, 25, 70-80. [PubMed]
35. Wilson, C.E.; Gillan, N.; Spain, D.; Robertson, D.; Roberts, G.; Murphy, C.M.; Maltezos, S.; Zinkstok, J.; Johnston, K.; Dardani, C et al. Comparison of ICD-10R, DSM-IV-TR and DSM-5 in an adult Autism Spectrum Disorder diagnostic clinic. J. Autism Dev. Disord. 2013, 43, 2515-2525. [CrossRef] [PubMed]
36. Zhang, X.; Ji, C.Y. Autism and mental retardation of young children in china. Biomed. Environ. Sci. 2005, 18, 334-340. [PubMed]
37. Baird, G.; Charman, T.; Baron-Cohen, S.; Cox, A.; Swettenham, J.; Wheelwright, S.; Drew, A. A screening instrument for autism at 18 months of age: A 6-year follow- up study. J. Am. Acad. Child Adolesc. Psychiatry 2000, 39, 694-702. [CrossRef] [PubMed]
38. Chakrabarti, S.; Fombonne, E. Pervasive Developmental Disorders in preschool children: Confirmation of high prevalence. Am. J. Psychiatry 2005, 162, 1133-1141. [CrossRef] [PubMed]
39. Arvidsson, T.; Danielsson, B.; Forsberg, P.; Gillberg, C.; Johansson, M.; Kjellgren, G. Autism in 3-6-year-old children in a suburb of goteborg, sweden. Autism 1997, 1, 163-173. [CrossRef]
40. Kadesjö, B.; Gillberg, C.; Hagberg, B. Brief report: Autism and asperger syndrome in seven-year-old children: A total population study. J. Autism Dev. Disord. 1999, 29, 327-327. [CrossRef] [PubMed]
41. Mattila, M.-L.; Kielinen, M.; Linna, S.-L.; Jussila, K.; Ebeling, H.; Bloigu, R.; Joseph, R.M.; Moilanen, I. Autism Spectrum Disorders according to DSM-IV-TR and comparison with DSM-5 draft criteria: An epidemiological study. J. Am. Acad. Child Adolesc. Psychiatry 2011, 50, 583-592. [CrossRef] [PubMed]
42. Eapen, V.; Mabrouk, A.A.; Zoubeidi, T.; Yunis, F. Prevalence of Pervasive Developmental Disorders in preschool children in the uae. J. Trop. Pediatr. 2007, 53, 202-205. [CrossRef] [PubMed]
43. Samadi, S.A.; Mahmoodizadeh, A.; McConkey, R. A national study of the prevalence of autism among five-year-old children in Iran. Autism 2012, 16, 5-14. [CrossRef] [PubMed]
44. Lejarraga, H.; Menendez, A.M.; Menzano, E.; Guerra, L.; Biancato, S.; Pianelli, P.; Del Pino, M.; Fattore, M.J.; Contreras, M.M. Screening for developmental problems at primary care level: A field programme in San Isidro, Argentina. Paediatr. Perinat. Epidemiol. 2008, 22, 180-187. [CrossRef] [PubMed]
45. Kawamura, Y.; Takahashi, O.; Ishii, T. Reevaluating the incidence of Pervasive Developmental Disorders: Impact of elevated rates of detection through implementation of an integrated system of screening in Toyota, Japan. Psychiatry Clin. Neurosci. 2008, 62, 152-159. [CrossRef] [PubMed]
46. Baxter, A.J.; Brugha, T.S.; Erskine, H.E.; Scheurer, R.W.; Vos, T.; Scott, J.G. The epidemiology and global burden of Autism Spectrum Disorders. Psychol. Med. 2015, 45, 601-613. [CrossRef] [PubMed]
47. Grant, W.B.; Soles, C.M. Epidemiologic evidence supporting the role of maternal vitamin d deficiency as a risk factor for the development of infantile autism. Dermatoendocrinology 2009, 1, 223-228. [CrossRef]
48. Piirainen, T.; Laitinen, K.; Isolauri, E. Impact of national fortification of fluid milks and margarines with vitamin D on dietary intake and serum 25-hydroxyvitamin D concentration in 4-year-old children. Eur. J. Clin. Nutr. 2006, 61, 123-128. [CrossRef] [PubMed]
49. Tylavsky, F.A.; Cheng, S.; Lyytikäinen, A.; Viljakainen, H.; Lamberg-Allardt, C. Strategies to improve vitamin D status in northern european children: Exploring the merits of vitamin D fortification and supplementation. J. Nutr. 2006, 136, 1130-1134. [PubMed]
50. Laaksi, I.T.; Ruohola, J.P.S.; Ylikomi, T.J.; Auvinen, A.; Haataja, R.I.; Pihlajamaki, H.K.; Tuohimaa, P.J. Vitamin D fortification as public health policy: Significant improvement in vitamin D status in young finnish men. Eur. J. Clin. Nutr. 2006, 60, 1035-1038. [CrossRef] [PubMed]
51. McAree, T.; Jacobs, B.; Manickavasagar, T.; Sivalokanathan, S.; Brennan, L.; Bassett, P.; Rainbow, S.; Blair, M. Vitamin D deficiency in pregnancy—Still a public health issue. Mater. Child. Nutr. 2013, 9, 23-30. [CrossRef] [PubMed]
52. Pena, H.R.; de Lima, M.C.; Brandt, K.G.; de Antunes, M.M.; da Silva, G.A. Influence of preeclampsia and gestational obesity in maternal and newborn levels of vitamin D. BMC Pregnancy Childbirth 2015, 15, 112. [CrossRef] [PubMed]
53. Saraf, R.; Morton, S.M.; Camargo, C.A.; Grant, C.C. Global summary of maternal and newborn vitamin D status—A systematic review. Mater. Child. Nutr. 2015. [CrossRef] [PubMed]
54. Ng, W.; Ikeda, S. Use of sun-protective items by Japanese pedestrians: A cross-sectional observational study. Arch. Dermatol. 2011, 147, 1167-1170. [CrossRef] [PubMed]
55. Brito, A.; Cori, H.; Olivares, M.; Fernanda Mujica, M.; Cediel, G.; Lopez de Romana, D. Less than adequate vitamin D status and intake in latin America and the Caribbean:A problem of unknown magnitude. Food Nutr. Bull. 2013, 34, 52-64. [CrossRef] [PubMed]
56. Xiao, J.P.; Zang, J.; Pei, J.J.; Xu, F.; Zhu, Y.; Liao, X.P. Low maternal vitamin D status during the second trimester of pregnancy: A cross-sectional study inWuxi, China. PLoS ONE 2015, 10, e0117748. [CrossRef] [PubMed]
57. Kelishadi, R.; Sharifi-Ghazvini, F.; Poursafa, P.; Mehrabian, F.; Farajian, S.; Yousefy, H.; Movahedian, M.; Sharifi-Ghazvini, S. Determinants of hypovitaminosis D in pregnant women and their newborns in a sunny region. Int. J. Endocrinol. 2013, 2013, 6. [CrossRef] [PubMed]
58. Al Anouti, F.; Thomas, J.; Abdel-Wareth, L.; Rajah, J.; Grant, W.B.; Haq, A. Vitamin D deficiency and sun avoidance among university students at Abu Dhabi, United Arab Emirates. Dermatoendocrinology 2011, 3, 235-239. [CrossRef] [PubMed]
59. Samadi, S.A.; McKonkey, R. Autism in developing countries: Lessons from Iran. Autism Res. Treat. 2011, 2011, 145359. [CrossRef] [PubMed]
60. Grant, W.B.; Cannell, J.J. Autism prevalence in the united states with respect to solar UV-B doses: An ecological study. Dermatoendocrinology 2013, 5, 159-164. [CrossRef] [PubMed]
61. Magnusson, C.; Rai, D.; Goodman, A.; Lundberg, M.; Idring, S.; Svensson, A.; Koupil, I.; Serlachius, E.; Dalman, C. Migration and Autism Spectrum Disorder: Population-based study. Br. J. Psychiatry 2012, 201, 109-115. [CrossRef] [PubMed]
62. Maimburg, R.D.; Vaeth, M. Perinatal risk factors and infantile autism. Acta Psychiatr. Scand. 2006, 114, 257-264. [CrossRef] [PubMed]
63. Keen, D.V.; Reid, F.D.; Arnone, D. Autism, ethnicity and maternal immigration. Br. J. Psychiatry 2010, 196, 274-281. [CrossRef] [PubMed]
64. Hultman, C.M.; Sparen, P.; Cnattingius, S. Perinatal risk factors for infantile autism. Epidemiology (Camb. Mass.) 2002, 13, 417-423. [CrossRef]
65. Lauritsen, M.B.; Pedersen, C.B.; Mortensen, P.B. Effects of familial risk factors and place of birth on the risk of autism: A nationwide register-based study. J. Child Psychol. Psychiatry 2005, 46, 963-971. [CrossRef] [PubMed]
66. Williams, K.; Helmer, M.; Duncan, G.W.; Peat, J.K.; Mellis, C.M. Perinatal and maternal risk factors for Autism Spectrum Disorders in new South Wales, Australia. Child. Care. Health Dev. 2008, 34, 249-256. [CrossRef] [PubMed]
67. Haglund, N.G.S.; Källén, K.B.M. Risk factors for autism and asperger syndrome: Perinatal factors and migration. Autism 2010. [CrossRef] [PubMed]
68. Croen, L.A.; Grether, J.K.; Selvin, S. Descriptive epidemiology of autism in a California population: Who is at risk? J. Autism Dev. Disord. 2002, 32, 217-224. [CrossRef] [PubMed]
69. Becerra, T.A.; von Ehrenstein, O.S.; Heck, J.E.; Olsen, J.; Arah, O.A.; Jeste, S.S.; Rodriguez, M.; Ritz, B. Autism Spectrum Dsiorders and race, ethnicity, and nativity: A population-based study. Pediatrics 2014, 134, e63-e71. [CrossRef] [PubMed]
70. van der Ven, E.; Termorshuizen, F.; Laan, W.; Breetvelt, E.J.; van Os, J.; Selten, J.P. An incidence study of diagnosed autism-spectrum disorders among immigrants to The Netherlands. Acta Psychiatr. Scand. 2013, 128, 54-60. [CrossRef] [PubMed]
71. Prevalence of Autism Spectrum Disorder among children aged 8 years—Autism and developmental disabilities monitoring network, 11 sites, United States, 2010. MMWR Surveill. Summ. 2014, 63, 1-21.
72. Croen, L.A.; Najjar, D.V.; Fireman, B.; Grether, J.K. Maternal and paternal age and risk of Autism Spectrum Disorders. Arch. Pediatr. Adolesc. Med. 2007, 161, 334-340. [CrossRef] [PubMed]
73. Tek, S.; Landa, R. Differences in autism symptoms between minority and non-minority toddlers. J. Autism Dev. Disord. 2012, 42, 1967-1973. [CrossRef] [PubMed]
74. Mazumdar, S.; Liu, K.Y.; Susser, E.; Bearman, P. The disappearing seasonality of autism conceptions in California. PLoS ONE 2012, 7, e41265. [CrossRef] [PubMed]
75. Zerbo, O.; Iosif, A.-M.; Delwiche, L.; Walker, C.; Hertz-Picciotto, I. Month of conception and risk of autism. Epidemiology (Camb. Mass.) 2011, 22, 469-475. [CrossRef] [PubMed]
76. Hebert, K.J.; Miller, L.L.; Joinson, C.J. Association of autistic spectrum disorder with season of birth and conception in a UK cohort. Autism Res. 2010, 3, 185-190. [CrossRef] [PubMed]
77. Atladottir, H.O.; Parner, E.T.; Schendel, D.; Dalsgaard, S.; Thomsen, P.H.; Thorsen, P. Variation in incidence of neurodevelopmental disorders with season of birth. Epidemiology (Camb. Mass.) 2007, 18, 240-245. [CrossRef] [PubMed]
78. Fernell, E.; Bejerot, S.; Westerlund, J.; Miniscalco, C.; Simila, H.; Eyles, D.; Gillberg, C.; Humble, M.B. Autism Spectrum Disorder and low vitamin D at birth: A sibling control study. Mol. Autism 2015, 6, 3. [CrossRef] [PubMed]
79. Uğur, Ç.; Gürkan, C.K. Serum vitamin D and folate levels in children with Autism Spectrum Disorders. Res. Autism Spectr. Disord. 2014, 8, 1641-1647. [CrossRef]
80. Maimburg, R.D.; Bech, B.H.; Væth, M.; Møller-Madsen, B.; Olsen, J. Neonatal jaundice, autism, and other disorders of psychological development. Pediatrics 2010, 126, 872-878. [CrossRef] [PubMed]
81. Meguid, N.A.; Hashish, A.F.; Anwar, M.; Sidhom, G. Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in egyptian children with autism. J. Altern. Complement. Med. (New York NY) 2010, 16, 641-645. [CrossRef] [PubMed]
82. Lee, L.C.; Newschaffer, C.J.; Lessler, J.T.; Lee, B.K.; Shah, R.; Zimmerman, A.W. Variation in season of birth in singleton and multiple births concordant for Autism Spectrum Disorders. Paediatr. Perinat. Epidemiol. 2008, 22, 172-179. [CrossRef] [PubMed]
83. Kolevzon, A.; Weiser, M.; Gross, R.; Lubin, G.; Knobler, H.Y.; Schmeidler, J.; Silverman, J.M.; Reichenberg, A. Effects of season of birth on Autism Spectrum Disorders: Fact or fiction? Am. J. Psychiatry 2006, 163, 1288-1290. [CrossRef] [PubMed]
84. Yeates-Frederikx, M.H.M.; Nijman, H.; Logher, E.; Merckelbach, H.L.G.J. Birth patterns in mentally retarded autistic patients. J. Autism Dev. Disord. 2000, 30, 257-262. [CrossRef] [PubMed]
85. Stevens, M.C.; Fein, D, Waterhouse, L.H. Season of birth effects in autism. J. Clin. Exp. Neuropsychol. 2000, 22, 399-407. [CrossRef]
86. Landau, E.C.; Cicchetti, D.V.; Klin, A.; Volkmar, F.R. Season of birth in autism: A fiction revisited. J. Autism Dev. Disord. 1999, 29, 385-393. [CrossRef] [PubMed]
87. Barak, Y.; Ring, A.; Sulkes, J.; Gabbay, U.; Elizur, A. Season of birth and autistic disorder in israel. Am. J. Psychiatry 1995, 152, 798-800. [PubMed]
88. Mouridsen, S.E.; Nielsen, S.; Rich, B.; Isager, T. Season of birth in infantile autism and other types of childhood psychoses. Child Psychiatry Hum. Dev. 1994, 25, 31-43. [CrossRef] [PubMed]
89. Bolton, P.; Pickles, A.; Harrington, R.; Macdonald, H.; Rutter, M. Season of birth: Issues, approaches and findings for autism. J. Child Psychol. Psychiatry 1992, 33, 509-530. [CrossRef] [PubMed]
90. Gillberg, C. Do children with autism have march birthdays? Acta Psychiatr. Scand. 1990, 82, 152-156. [CrossRef] [PubMed]
91. Tanoue, Y.; Oda, S.; Asano, F.; Kawashima, K. Epidemiology of infantile autism in southern Ibaraki, Japan: Differences in prevalence in birth cohorts. J. Autism Dev. Disord. 1988, 18, 155-166. [CrossRef] [PubMed]
92. Konstantareas, M.M.; Hauser, P.; Lennox, C.; Homatidis, S. Season of birth in infantile autism. Child Psychiatry Hum. Dev. 1986, 17, 53-65. [CrossRef] [PubMed]
93. Kanan, R.M.; Al Saleh, Y.M.; Fakhoury, H.M.; Adham, M.; Aljaser, S.; Tamimi, W. Year-round vitamin D deficiency among saudi female out-patients. Public Health Nutr. 2013, 16, 544-548. [CrossRef] [PubMed]
94. Whitehouse, A.J.; Holt, B.J.; Serralha, M.; Holt, P.G.; Kusel, M.M.; Hart, P.H. Maternal serum vitamin D levels during pregnancy and offspring neurocognitive development. Pediatrics 2012, 129, 485-493. [CrossRef] [PubMed]
95. Shelton, J.F.; Geraghty, E.M.; Tancredi, D.J.; Delwiche, L.D.; Schmidt, R.J.; Ritz, B.; Hansen, R.L.; Hertz-Picciotto, I. Neurodevelopmental disorders and prenatal residential proximity to agricultural pesticides: The charge study. Environ. Health Perspect. 2014, 122, 1103-1109. [CrossRef] [PubMed]
96. Lee, B.K.; Magnusson, C.; Gardner, R.M.; Blomstrom, A.; Newschaffer, C.J.; Burstyn, I.; Karlsson, H.; Dalman, C. Maternal hospitalization with infection during pregnancy and risk of Autism Spectrum Disorders. Brain Behav. Immun. 2015, 44, 100-105. [CrossRef] [PubMed]
97. Lyall, K.; Schmidt, R.J.; Hertz-Picciotto, I. Maternal lifestyle and environmental risk factors for Autism Spectrum Disorders. Int. J. Epidemiol. 2014, 43, 443-464. [CrossRef] [PubMed]
98. Xu, X.-J.; Shou, X.-J.; Li, J.; Jia, M.-X.; Zhang, J.-S.; Guo, Y.; Wei, Q.-Y.; Zhang, X.-T.; Han, S.-P.; Zhang, R et al. Mothers of autistic children: Lower plasma levels of oxytocin and arg-vasopressin and a higher level of testosterone. PLoS ONE 2013, 8, e74849. [CrossRef] [PubMed]
99. Fernell, E.; Barnevik-Olsson, M.; Bågenholm, G.; Gillberg, C.; Gustafsson, S.; Sääf, M. Serum levels of 25-hydroxyvitamin D in mothers of swedish and of somali origin who have children with and without autism. Acta Paediatr. 2010, 99, 743-747. [CrossRef] [PubMed]
100. Whitehouse, A.O.; Holt, B.; Serralha, M.; Holt, P.; Hart, P.; Kusel, M.H. Maternal vitamin D levels and the autism phenotype among offspring. J. Autism Dev. Disord. 2013, 43, 1495-1504. [CrossRef] [PubMed]
101. Wakayo, T.; Belachew, T.; Vatanparast, H.; Whiting, S.J. Vitamin D deficiency and its predictors in a country with thirteen months of sunshine: The case of school children in central Ethiopia. PLoS ONE 2015, 10, e0120963. [CrossRef] [PubMed]
102. Rabenberg, M.; Scheidt-Nave, C.; Busch, M.A.; Rieckmann, N.; Hintzpeter, B.; Mensink, G.B.M. Vitamin D status among adults in germany—Results from the German health interview and examination survey for adults (DEGS1). BMC Public Health 2015, 15, 1-15. [CrossRef] [PubMed]
103. Morales, E.; Guxens, M.; Llop, S.; Rodríguez-Bernal, C.L.; Tardón, A.; Riaño, I.; Ibarluzea, J.; Lertxundi, N.; Espada, M.; Rodriguez, A et al. Circulating 25-hydroxyvitamin D3 in pregnancy and infant neuropsychological development. Pediatrics 2012, 130, e913-e920. [CrossRef] [PubMed]
104. Gale, C.R.; Robinson, S.M.; Harvey, N.C.; Javaid, M.K.; Jiang, B.; Martyn, C.N.; Godfrey, K.M.; Cooper, C.; The Princess Anne Hospital Study Group. Maternal vitamin D status during pregnancy and child outcomes. Eur. J. Clin. Nutr. 2008, 62, 68-77. [CrossRef] [PubMed]
105. Groves, N.J.; McGrath, J.J.; Burne, T.H.J. Vitamin D as a neurosteroid affecting the developing and adult brain. Annu. Rev. Nutr. 2014, 34, 117-141. [CrossRef] [PubMed]
106. Stubbs, G.; Henley, K.; Green, J. Autism: Will vitamin D supplementation during pregnancy and early childhood reduce the recurrence rate of autism in newborn siblings? Med. Hypotheses 2016, 88, 74-78. [CrossRef] [PubMed]
107. Du, L.; Shan, L.; Wang, B.; Feng, J.Y.; Xu, Z.D.; Jia, F.Y. Serum levels of 25-hydroxyvitamin D in children with Autism Spectrum Disorders. Zhongguo Dang Dai Er Ke Za Zhi 2015, 17, 68-71. [PubMed]
108. Kocovska, E.; Andorsdottir, G.; Weihe, P.; Halling, J.; Fernell, E.; Stora, T.; Biskupsto, R.; Gillberg, I.C.; Shea, R.; Billstedt, E et al. Vitamin D in the general population of young adults with autism in the faroe islands. J. Autism Dev. Disord. 2014, 44, 2996-3005. [CrossRef] [PubMed]
109. Mostafa, G.A.; Al-Ayadhi, L.Y. Reduced serum concentrations of 25-hydroxy vitamin D in children with autism: Relation to autoimmunity. J. Neuroinflamm. 2012, 9, 201. [CrossRef] [PubMed]
110. Tostes, M.H.F.D.S.; Polonini, H.C.; Gattaz, W.F.; Raposo, N.R.B.; Baptista, E.B. Low serum levels of 25-hydroxyvitamin D (25-OHD) in children with autism. Trends Psychiatry Psychother. 2012, 34, 161-163. [CrossRef] [PubMed]
111. Saad, K.; Abdel-Rahman, A.A.; Elserogy, Y.M.; Al-Atram, A.A.; Cannell, J.J.; Bjorklund, G.; Abdel-Reheim, M.K.; Othman, H.A.; El-Houfey, A.A.; Abd El-Aziz, N.H et al. Vitamin D status in Autism Spectrum Disorders and the efficacy of vitamin D supplementation in autistic children. Nutr. Neurosci. 2015. [CrossRef] [PubMed]
112. Gong, Z.L.; Luo, C.M, Wang, L.; Shen, L, Wei, F.; Tong, R.J.; Liu, Y. Serum 25-hydroxyvitamin D levels in Chinese children with Autism Spectrum Disorders. Neuroreport 2014, 25, 23-27. [CrossRef] [PubMed]
113. Molloy, C.A.; Kalkwarf, H.J.; Manning-Courtney, P.; Mills, J.L.; Hediger, M.L. Plasma 25(OH)D concentration in children with Autism Spectrum Disorder. Dev. Med. Child Neurol. 2010, 52, 969-971. [CrossRef] [PubMed]
114. Neumeyer, A.M.; Gates, A.; Ferrone, C.; Lee, H.; Misra, M. Bone density in peripubertal boys with Autism Spectrum Disorders. J. Autism Dev. Disord. 2013, 43, 1623-1629. [CrossRef] [PubMed]
115. Hashemzadeh, M.; Moharreri, F.; Soltanifar, A. Comparative study of vitamin D levels in children with Autism Spectrum Disorder and normal children: A case-control study. J. Fundam. Ment. Health 2015, 17, 197-201.
116. Adams, J.B.; Audhya, T.; McDonough-Means, S.; Rubin, R.A.; Quig, D.; Geis, E.; Gehn, E.; Loresto, M.; Mitchell, J.; Atwood, S et al. Nutritional and metabolic status of children with autism vs. neurotypical children, and the association with autism severity. Nutr. Metab. (Lond.) 2011, 8, 34. [CrossRef] [PubMed]
117. Feng, J.; Shan, L.; Du, L.; Wang, B.; Li, H.; Wang, W.; Wang, T.; Dong, H.; Yue, X.; Xu, Z et al. Clinical improvement following vitamin D3 supplementation in Autism Spectrum Disorder. Nutr. Neurosci. 2016. [CrossRef] [PubMed]
118. Bener, A.; Khattab, A.O.; Al-Dabbagh, M.M. Is high prevalence of vitamin D deficiency evidence for autism disorder? In a highly endogamous population. J. Pediatr. Neurosci. 2014, 9, 227-233. [CrossRef] [PubMed]
119. Humble, M.B.; Gustafsson, S.; Bejerot, S. Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: Relations with season, age, ethnic origin and psychiatric diagnosis. J. Steroid Biochem. Mol. Biol. 2010, 121, 467-470. [CrossRef] [PubMed]
120. Waldron, J.L.; Ashby, H.L.; Cornes, M.P.; Bechervaise, J.; Razavi, C.; Thomas, O.L.; Chugh, S.; Deshpande, S.; Ford, C.; Gama, R. Vitamin D: A negative acute phase reactant. J. Clin. Pathol. 2013, 66, 620-622. [CrossRef] [PubMed]
121. Hummel, D.M.; Fetahu, I.S.; Gröschel, C.; Manhardt, T.; Kállay, E. Role of proinflammatory cytokines on expression of vitamin D metabolism and target genes in colon cancer cells. J. Steroid Biochem. Mol. Biol. 2014, 144, 91-95. [CrossRef] [PubMed]
122. Ozkan, B.; Doneray, H.; Karacan, M.; Vançelik, S.; Yildirim, Z.K.; Ozkan, A.; Kosan, C.; Aydin, K. Prevalence of vitamin D deficiency rickets in the eastern part of Turkey. Eur. J. Pediatr. 2009, 168, 95-100. [CrossRef] [PubMed]
123. Khayyat, Y.; Attar, S. Vitamin D deficiency in patients with irritable bowel syndrome: Does it exist? Oman Med. J. 2015, 30, 115-118. [CrossRef] [PubMed]
124. Joseph, A.J.; George, B.; Pulimood, A.B.; Seshadri, M.S.; Chacko, A. 25 (OH) vitamin D level in crohn’s disease: Association with sun exposure and disease activity. Indian J. Med. Res. 2009, 130, 133-137. [PubMed]
125. Menon, B.; Harinarayan, C.V. The effect of anti epileptic drug therapy on serum 25-hydroxyvitamin D and parameters of calcium and bone metabolism—A longitudinal study. Seizure 2010, 19, 153-158. [CrossRef] [PubMed]
126. Stewart, P.A.; Hyman, S.L.; Schmidt, B.L.; Macklin, E.A.; Reynolds, A.; Johnson, C.R.; James, S.J.; Manning-Courtney, P. Dietary supplementation in children with Autism Spectrum Disorders: Common, insufficient, and excessive. J. Acad. Nutr. Diet. 2015, 115, 1237-1248. [CrossRef] [PubMed]
127. Must, A.; Phillips, S.M.; Curtin, C.; Anderson, S.E.; Maslin, M.; Lividini, K.; Bandini, L.G. Comparison of sedentary behaviors between children with Autism Spectrum Disorders and typically developing children. Autism 2013. [CrossRef] [PubMed]
128. Emond, A.; Emmett, P.; Steer, C.; Golding, J. Feeding symptoms, dietary patterns, and growth in young children with Autism Spectrum Disorders. Pediatrics 2010, 126, e337-e342. [CrossRef] [PubMed]
129. Zimmer, M.; Hart, L.; Manning-Courtney, P.; Murray, D.; Bing, N.; Summer, S. Food variety as a predictor of nutritional status among children with autism. J. Autism Dev. Disord. 2012, 42, 549-556. [CrossRef] [PubMed]
130. Bandini, L.G.; Anderson, S.E.; Curtin, C.; Cermak, S.; Evans, E.W.; Scampini, R.; Maslin, M.; Must, A. Food selectivity in children with Autism Spectrum Disorders and typically developing children. J. Pediatr. 2010, 157, 259-264. [CrossRef] [PubMed]
131. Marí-Bauset, S.; Llopis-González, A.; Zazpe-García, I.; Marí-Sanchis, A.; Morales-Suárez-Varela, M. Nutritional status of children with Autism Spectrum Disorders (ASDs): A case—Control study. J. Autism Dev. Disord. 2015, 45, 203-212. [CrossRef] [PubMed]
132. Hyman, S.L.; Stewart, P.A.; Schmidt, B.; Cain, U.; Lemcke, N.; Foley, J.T.; Peck, R.; Clemons, T.; Reynolds, A.; Johnson, C et al. Nutrient intake from food in children with autism. Pediatrics 2012, 130 (Suppl. 2), S145-S153. [CrossRef] [PubMed]
133. Moore, E.; Crook, T.; James, J.; Gonzales, D.; Hakkak, R. Nutrient intake among children with autism. J. Nutr. Disord. Ther. 2012. [CrossRef]
134. Cornish, E. A balanced approach towards healthy eating in autism. J. Hum. Nutr. Diet. 1998, 11, 501-509. [CrossRef]
135. Lindsay, R.L.; Eugene Arnold, L.; Aman, M.G.; Vitiello, B.; Posey, D.J.; McDougle, C.J.; Scahill, L.; Pachler, M.; McCracken, J.T.; Tierney, E et al. Dietary status and impact of risperidone on nutritional balance in children with autism: A pilot study. J. Intellect. Dev. Disabil. 2006, 31, 204-209. [CrossRef] [PubMed]
136. Williams-Hooker, R.; George, E.O.; Levy, M.; Morgan, C.; Smith, T.L.; Bittle, J.B. Calcium and vitamin D intake of boys who have autism. Infant Child Adolesc. Nutr. 2013, 5, 113-117. [CrossRef]
137. Graf-Myles, J.; Farmer, C.; Thurm, A.; Royster, C.; Kahn, P.; Soskey, L.; Rothschild, L.; Swedo, S. Dietary adequacy of children with autism compared with controls and the impact of restricted diet. J. Dev. Behav. Pediatr. 2013, 34, 449-459. [CrossRef] [PubMed]
138. Herndon, A.; DiGuiseppi, C.; Johnson, S.; Leiferman, J.; Reynolds, A. Does nutritional intake differ betwe n children with Autism Spectrum Disorders and children with typical development? J. Autism Dev. Disord. 2009, 39, 212-222. [CrossRef] [PubMed]
139. Jia, F.; Wang, B.; Shan, L.; Xu, Z.; Staal, W.G.; Du, L. Core symptoms of autism improved after vitamin D supplementation. Pediatrics 2015, 135, e196-e198. [CrossRef] [PubMed]
140. Azzam, H.M.E.; Sayyah, H.; Youssef, S.; Lotfy, H.; Abdelhamid, I.A.; Abd Elhamed, H.A.; Maher, S. Autism and vitamin D: An intervention study. Middle East Curr. Psychiatry 2015, 22, 9-14. [CrossRef]
141. Ucuz, ˙I.˙I.; Dursun, O.B.; Esin, ˙I.S; Kurt, N.; Kiziltunç, A.; Orbak, Z. The relationship between vitamin D, autistic spectrum disorders, and cognitive development: Do glial cell line-derived neurotrophic factor and nerve growth factor play a role in this relationship? Int. J. Dev. Disabil. 2015, 61, 222-230. [CrossRef]
142. Corrigan, N.M.; Shaw, D.W.; Estes, A.M.; Richards, T.L.; Munson, J.; Friedman, S.D.; Dawson, G.; Artru, A.A.; Dager, S.R. Atypical developmental patterns of brain chemistry in children with Autism Spectrum Disorder. JAMA Psychiatry 2013, 70, 964-974. [CrossRef] [PubMed]
143. Cass, W.A.; Smith, M.P.; Peters, L.E. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Ann. N. Y. Acad. Sci. 2006, 1074, 261-271. [CrossRef] [PubMed]
144. Eyles, D.W.; Smith, S.; Kinobe, R.; Hewison, M.; McGrath, J.J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanat. 2005, 29, 21-30. [CrossRef] [PubMed]
145. Cui, X.; Pelekanos, M.; Liu, P.Y.; Burne, T.H.J.; McGrath, J.J.; Eyles, D.W. The vitamin D receptor in dopamine neurons; its presence in human substantia nigra and its ontogenesis in rat midbrain. Neuroscience 2013, 236, 77-87. [CrossRef] [PubMed]
146. Frazier, T.W.; Thompson, L.; Youngstrom, E.A.; Law, P.; Hardan, A.Y.; Eng, C.; Morris, N. A twin study of heritable and shared environmental contributions to autism. J. Autism Dev. Disord. 2014, 44, 2013-2025. [CrossRef] [PubMed]
147. Sandin, S.; Lichtenstein, P.; Kuja-Halkola, R.; Larsson, H.; Hultman, C.M.; Reichenberg, A. The familial risk of autism. JAMA 2014, 311, 1770-1777. [CrossRef] [PubMed]
148. Schmidt, R.J.; Hansen, R.L.; Hartiala, J.; Allayee, H.; Sconberg, J.L.; Schmidt, L.C.; Volk, H.E.; Tassone, F. Selected vitamin D metabolic gene variants and risk for Autism Spectrum Disorder in the charge study. Early Hum. Dev. 2015, 91, 483-489. [CrossRef] [PubMed]
149. Nair-Shalliker, V.; Armstrong, B.K.; Fenech, M. Does vitamin D protect against DNA damage? Mutat. Res-Fund. Mol. Mech. Mut. 2012, 733, 50-57. [CrossRef] [PubMed]
150. Fedirko, V.; Bostick, R.M.; Long, Q.; Flanders, W.D.; McCullough, M.L.; Sidelnikov, E.; Daniel, C.R.; Rutherford, R.E.; Shaukat, A. Effects of supplemental vitamin D and calcium on oxidative DNA damage marker in normal colorectal mucosa: A randomized clinical trial. Cancer Epidemiol. Biomark. Prev. 2010, 19, 280-291. [CrossRef] [PubMed]
151. Mabley, J.G.; Wallace, R.; Pacher, P.; Murphy, K.; Szabó, C. Inhibition of poly(adenosine diphosphate-ribose) polymerase by the active form of vitamin D. Int. J. Mol. Med. 2007, 19, 947-952. [CrossRef] [PubMed]
152. Chatterjee, M. Vitamin D and genomic stability. Mutat. Res-Fund. Mol. Mech. Mut. 2001, 475, 69-87. [CrossRef]
153. James, S.J.; Cutler, P.; Melnyk, S.; Jernigan, S.; Janak, L.; Gaylor, D.W.; Neubrander, J.A. Metabolic biomarkers of increased oxidative stress and impaired methylation capacity in children with autism. Am. J. Clin. Nutr. 2004, 80, 1611-1617. [PubMed]
154. Alvarez, J.A.; Chowdhury, R.; Jones, D.P.; Martin, G.S.; Brigham, K.L.; Binongo, J.N.; Ziegler, T.R.; Tangpricha, V. Vitamin D status is independently associated with plasma glutathione and cysteine thiol/disulphide redox status in adults. Clin. Endocrinol. 2014, 81, 458-466. [CrossRef] [PubMed]
155. Codoner-Franch, P.; Tavarez-Alonso, S.; Simo-Jorda, R.; Laporta-Martin, P.; Carratala-Calvo, A.; Alonso-Iglesias, E. Vitamin D status is linked to biomarkers of oxidative stress, inflammation, and endothelial activation in obese children. J. Pediatr. 2012, 161, 848-854. [CrossRef] [PubMed]
156. Alfawaz, H.; Bhat, R.; Al-Ayadhi, L.; El-Ansary, A. Protective and restorative potency of vitamin D on persistent biochemical autistic features induced in propionic acid-intoxicated rat pups. BMC Complement. Altern. Med. 2014, 14, 1-10. [CrossRef] [PubMed]
157. Alabdali, A.; Al-Ayadhi, L.; El-Ansary, A. A key role for an impaired detoxification mechanism in the etiology and severity of Autism Spectrum Disorders. Behav. Brain Func. 2014, 10, 14. [CrossRef] [PubMed]
158. Shinpo, K.; Kikuchi, S.; Sasaki, H.; Moriwaka, F.; Tashiro, K. Effect of 1,25-dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by l-buthionine sulfoximine and 1-methyl-4-phenylpyridine. J. Neurosci. Res. 2000, 62, 374-382. [CrossRef]
159. Garcion, E.; Sindji, L.; Leblondel, G.; Brachet, P.; Darcy, F. 1,25-dihydroxyvitamin D3 regulates the synthesis of -glutamyl transpeptidase and glutathione levels in rat primary astrocytes. J. Neurochem. 1999, 73, 859-866. [CrossRef] [PubMed]
160. Morgan, J.T.; Chana, G.; Pardo, C.A.; Achim, C.; Semendeferi, K.; Buckwalter, J.; Courchesne, E.; Everall, I.P. Microglial activation and increased microglial density observed in the dorsolateral prefrontal cortex in autism. Biol. Psychiatry 2010, 68, 368-376. [CrossRef] [PubMed]
161. Vargas, D.L.; Nascimbene, C.; Krishnan, C.; Zimmerman, A.W.; Pardo, C.A. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann. Neurol. 2005, 57, 67-81. [CrossRef] [PubMed]
162. Almerighi, C.; Sinistro, A.; Cavazza, A.; Ciaprini, C.; Rocchi, G.; Bergamini, A. 1,25-dihydroxyvitamin D3 inhibits CD40l-induced pro-inflammatory and immunomodulatory activity in human monocytes. Cytokine 2009, 45, 190-197. [CrossRef] [PubMed]
163. Heine, G.; Niesner, U.; Chang, H.-D.; Steinmeyer, A.; Zügel, U.; Zuberbier, T.; Radbruch, A.; Worm, M. 1,25-dihydroxyvitamin D3 promotes IL-10 production in human b cells. Eur. J. Immunol. 2008, 38, 2210-2218. [CrossRef] [PubMed]
164. Széles, L.; Keresztes, G.; Töröcsik, D.; Balajthy, Z.; Krenács, L.; Póliska, S.; Steinmeyer, A.; Zuegel, U.; Pruenster, M.; Rot, A et al. 1,25-dihydroxyvitamin D3 is an autonomous regulator of the transcriptional changes leading to a tolerogenic dendritic cell phenotype. J. Immunol. 2009, 182, 2074-2083. [CrossRef] [PubMed]
165. Mostafa, G.A.; Al-ayadhi, L.Y. Increased serum levels of anti-ganglioside m1 auto-antibodies in autistic children: Relation to the disease severity. J. Neuroinflamm. 2011, 8, 39. [CrossRef] [PubMed]
166. Mostafa, G.A.; Kitchener, N. Serum anti-nuclear antibodies as a marker of autoimmunity in egyptian autistic children. Pediatr. Neurol. 2009, 40, 107-112. [CrossRef] [PubMed]
167. Mostafa, G.A.; Al-Ayadhi, L.Y. The relationship between the increased frequency of serum antineuronal antibodies and the severity of autism in children. Eur. J. Paediatr. Neurol. 2012, 16, 464-468. [CrossRef] [PubMed]
168. Mostafa, G.A.; El-Sayed, Z.A.; El-Aziz, M.M.; El-Sayed, M.F. Serum anti-myelin-associated glycoprotein antibodies in egyptian autistic children. J. Child Neurol. 2008, 23, 1413-1418. [CrossRef] [PubMed]
169. Jung, J.Y.; Kohane, I.S.; Wall, D.P. Identification of autoimmune gene signatures in autism. Transl. Psychiatry 2011, 1, e63. [CrossRef] [PubMed]
170. Zikopoulos, B.; Barbas, H. Changes in prefrontal axons may disrupt the network in autism. J. Neurosci. 2010, 30, 14595-14609. [CrossRef] [PubMed]
171. Dendrou, C.A.; Fugger, L.; Friese, M.A. Immunopathology of multiple sclerosis. Nat. Rev. Immunol. 2015, 15, 545-558. [CrossRef] [PubMed]
172. Ritterhouse, L.L.; Crowe, S.R.; Niewold, T.B.; Kamen, D.L.; Macwana, S.R.; Roberts, V.C.; Dedeke, A.B.; Harley, J.B.; Scofield, R.H.; Guthridge, J.M et al. Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 2011, 70, 1569-1574. [CrossRef] [PubMed]
173. Chabas, J.-F.; Stephan, D.; Marqueste, T.; Garcia, S.; Lavaut, M.-N.; Nguyen, C.; Legre, R.; Khrestchatisky, M.; Decherchi, P.; Feron, F. Cholecalciferol (vitamin D3) improves myelination and recovery after nerve injury. PLoS ONE 2013, 8, e65034. [CrossRef] [PubMed]
174. Mokry, L.E.; Ross, S.; Ahmad, O.S.; Forgetta, V.; Smith, G.D.; Leong, A.; Greenwood, C.M.; Thanassoulis, G.; Richards, J.B. Vitamin D and risk of multiple sclerosis: A mendelian randomization study. PLoS Med. 2015, 12, e1001866. [CrossRef] [PubMed]
175. Wang, M.; Chen, H.; Yu, T.; Cui, G.; Jiao, A.; Liang, H. Increased serum levels of brain-derived neurotrophic factor in Autism Spectrum Disorder. Neuroreport 2015, 26, 638-641. [CrossRef] [PubMed]
176. Dincel, N.; Unalp, A.; Kutlu, A.; Ozturk, A.; Uran, N.; Ulusoy, S. Serum nerve growth factor levels in autistic children in turkish population: A preliminary study. Indian J. Med. Res. 2013, 138, 900-903. [PubMed]
177. Neveu, I.; Naveilhan, P.; Jehan, F.D.R.; Baudet, C, Wion, D.; De Luca, H.F.; Brachet, P. 1,25-dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Mol. Brain Res. 1994, 24, 70-76. [CrossRef]
178. Brown, J.; Bianco, J.I.; McGrath, J.J.; Eyles, D.W. 1,25-dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci. Lett. 2003, 343, 139-143. [CrossRef]
179. Pozzi, F.; Aloe, L.; Frajese, G.V.; Frajese, G. Vitamin D (Calcifediol) supplementation modulates NGF and BDNF and improvesmemory function in postmenopausal women: A pilot study. Res. Endocrinol. 2013, 2013. [CrossRef]
180. Crockett, M.J.; Clark, L.; Tabibnia, G.; Lieberman, M.D.; Robbins, T.W. Serotonin modulates behavioral reactions to unfairness. Science 2008, 320, 1739. [CrossRef] [PubMed]
181. Anagnostou, E.; Soorya, L.; Chaplin, W.; Bartz, J.; Halpern, D, Wasserman, S, Wang, A.T.; Pepa, L.; Tanel, N.; Kushki, A et al. Intranasal oxytocin versus placebo in the treatment of adults with Autism Spectrum Disorders: A randomized controlled trial. Mol. Autism 2012, 3, 1. [CrossRef] [PubMed]
182. Naranjo, C.A.; Tremblay, L.K.; Busto, U.E. The role of the brain reward system in depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 2001, 25, 781-823. [CrossRef]
183. Staal, W.; de Krom, M.; de Jonge, M. Brief report: The dopamine-3-receptor gene (DRD3) is associated with specific repetitive behavior in Autism Spectrum Disorder (ASD). J. Autism Dev. Disord. 2012, 42, 885-888. [CrossRef] [PubMed]
184. Nakamura, K.; Sekine, Y.; Ouchi, Y.; Tsujii, M.; Yoshikawa, E.; Futatsubashi, M.; Tsuchiya, K.J.; Sugihara, G.; Iwata, Y.; Suzuki, K et al. Brain serotonin and dopamine transporter bindings in adults with high-functioning autism. Arch. Gen. Psychiatry 2010, 67, 59-68. [CrossRef] [PubMed]
185. Modahl, C.; Green, L.; Fein, D.; Morris, M.; Waterhouse, L.; Feinstein, C.; Levin, H. Plasma oxytocin levels in autistic children. Biol. Psychiatry 1998, 43, 270-277. [CrossRef]
186. Chugani, D.C.; Muzik, O.; Behen, M.; Rothermel, R.; Janisse, J.J.; Lee, J.; Chugani, H.T. Developmental changes in brain serotonin synthesis capacity in autistic and nonautistic children. Ann. Neurol. 1999, 45, 287-295. [CrossRef]
187. Mulder, E.J.; Anderson, G.M.; Kema, I.P.; de Bildt, A.; van Lang, N.D.; den Boer, J.A.; Minderaa, R.B. Platelet serotonin levels in Pervasive Developmental Disorders and mental retardation: Diagnostic group differences, within-group distribution, and behavioral correlates. J. Am. Acad. Child Adolesc. Psychiatry 2004, 43, 491-499. [CrossRef] [PubMed]
188. Cartier, E.; Hamilton, P.J.; Belovich, A.N.; Shekar, A.; Campbell, N.G.; Saunders, C.; Andreassen, T.F.; Gether, U.; Veenstra-Vanderweele, J.; Sutcliffe, J.S et al. Rare autism-associated variants implicate syntaxin 1 (STX1 R26Q) phosphorylation and the dopamine transporter (HDAT R51W) in dopamine neurotransmission and behaviors. EBioMedicine 2015, 2, 135-146. [CrossRef] [PubMed]
189. Patrick, R.P.; Ames, B.N. Vitamin D hormone regulates serotonin synthesis. Part 1: Relevance for autism. FASEB J. 2014, 28, 2398-2413. [CrossRef] [PubMed]
190. Frye, R.E. Metabolic and mitochondrial disorders associated with epilepsy in children with Autism Spectrum Disorder. Epilepsy Behav. 2015, 47, 147-157. [CrossRef] [PubMed]
191. Yasuhara, A. Correlation between eeg abnormalities and symptoms of Autism Spectrum Disorder (ASD). Brain Dev. 2010, 32, 791-798. [CrossRef] [PubMed]
192. Hara, H. Autismand epilepsy: Aretrospective follow-up study. BrainDev. 2007, 29, 486-490. [CrossRef] [PubMed]
193. Bromley, R.L.; Mawer, G.; Clayton-Smith, J.; Baker, G.A. Autism Spectrum Disorders following in utero exposure to antiepileptic drugs. Neurology 2008, 71, 1923-1924. [CrossRef] [PubMed]
194. Kalueff, A.V.; Minasyan, A.; Tuohimaa, P. Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res. Bull. 2005, 67, 156-160. [CrossRef] [PubMed]
195. Borowicz, K.K.; Morawska, M.; Furmanek-Karwowska, K.; Luszczki, J.J.; Czuczwar, S.J. Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock. Eur. J. Pharmacol. 2007, 573, 111-115. [CrossRef] [PubMed]
196. Siegel, A.; Malkowitz, L.; Moskovits, M.J.; Christakos, S. Administration of 1,25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res. 1984, 298, 125-129. [CrossRef]
197. Holló, A.; Clemens, Z.; Kamondi, A.; Lakatos, P. Correction of vitamin D deficiency improves seizure control in epilepsy: A pilot study. Epilepsy Behav. 2012, 24, 131-133. [CrossRef] [PubMed]
198. Christiansen, C.; Rødbro, P.; Sjö, O. “Anticonvulsant action” of vitamin D in epileptic patients? A controlled pilot study. Br. Med. J. 1974, 2, 258-259. [CrossRef] [PubMed]
199. Kalueff, A.V.; Eremin, K.O.; Tuohimaa, P. Mechanisms of neuroprotective action of vitamin D3. Biochemistry 2004, 69, 738-741. [CrossRef] [PubMed]